share_log

HC Wainwright & Co. Downgrades TherapeuticsMD to Neutral, Announces $10 Price Target

Benzinga Real-time News ·  Jun 7, 2022 07:24

HC Wainwright & Co. analyst Douglas Tsao downgrades TherapeuticsMD (NASDAQ:TXMD) from Buy to Neutral and announces $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment